Clinical Manifestation of Nebulin-Associated Nemaline Myopathy

Background And Objectives: Nemaline myopathy (NM) is a genetically heterogeneous inherited myopathy related with at least 12 genes, whereas pathogenic variants in gene are the most common genetic cause. The clinical spectrum of NM caused by NEB pathogenic variants (NM-) is very broad, ranging from mild to severe presentations manifesting with generalized weakness, as well as respiratory and bulbar involvement. There is currently not enough data regarding the progression of the disease. In this study, we present a genotypic and phenotypic spectrum of 33 patients with NM caused by NEB variants (NM-) classified according to age groups and the use of ventilatory support. We focused on interventional support, genotype-phenotype correlation, and association between respiratory, bulbar, and motor systems in groups of patients stratified by age and by the use of ventilatory support (VS).

Methods: Clinical and genetic data from patients with NM-NEB followed up in one specialized center were collected through regular consultations. Patients were evaluated regarding motor, bulbar, and respiratory functions.

Results: Thirty-three patients with NM-NEB were evaluated consisting of 15 females and 18 males with an average age of 18 (±12) years and a median of 17 (±11) years. 32% of patients with NM-NEB used a G tube, 35% were not able to walk without support, and 55% needed VS. Scoliosis and dysphagia were more common among patients who used VS. Described for the first time, half of the patients presented tongue atrophy in a triple furrow pattern, and the presence of the atrophy was associated with dysphagia. Comparing the patients grouped by age, we found that, proportionally, older patients had more scoliosis and respiratory dysfunction than younger groups, suggesting the progression of the disease in these domains. In addition to that, we showed that VS use was associated with scoliosis and dysphagia.

Discussion: NM-NEB is a very debilitating disease. There is an association between scoliosis and respiratory dysfunction while patients using VS have more often scoliosis than the no-VS group. Triple furrow tongue atrophy is a novel and frequent finding, which is directly associated with dysphagia. Grouping patients by age suggested disease stability in motor and swallow function, but a progression in respiratory dysfunction and skeletal deformities. All observations are relevant in the management care of patients with NM.

Citing Articles

Dysphagia in Rare Diseases and Syndromes: Current Approaches to Management and Therapeutic Innovations-A Systematic Review.

Papadopoulou S, Anagnostopouplou A, Katsarou D, Megari K, Efthymiou E, Argyriadis A Healthcare (Basel). 2025; 13(1.

PMID: 39791659 PMC: 11720206. DOI: 10.3390/healthcare13010052.

Generation of a novel mouse model of nemaline myopathy due to recurrent exon 55 deletion.

Coulson Z, Kolb J, Sabha N, Karimi E, Hourani Z, Ottenheijm C Res Sq. 2025; .

PMID: 39764134 PMC: 11702780. DOI: 10.21203/rs.3.rs-5456324/v1.

Nemaline myopathy with scoliosis: a case report.

Huang J, Zhang C, Li J, Wang H, Cui X, Wang J Front Pediatr. 2024; 12:1413096.

PMID: 39474605 PMC: 11518715. DOI: 10.3389/fped.2024.1413096.

Resolving intra-repeat variation in medically relevant VNTRs from short-read sequencing data using the cardiovascular risk gene LPA as a model.

Di Maio S, Zoscher P, Weissensteiner H, Forer L, Schachtl-Riess J, Amstler S Genome Biol. 2024; 25(1):167.

PMID: 38926899 PMC: 11201333. DOI: 10.1186/s13059-024-03316-5.

A Rare Case Report of Dental and Craniofacial Manifestations of Nemaline Myopathy.

Badnaware S, Gupta P Cureus. 2023; 15(11):e49091.

PMID: 38125243 PMC: 10731564. DOI: 10.7759/cureus.49091.

References

Sagath L, Lehtokari V, Valipakka S, Vihola A, Gardberg M, Hackman P . Congenital asymmetric distal myopathy with hemifacial weakness caused by a heterozygous large de novo mosaic deletion in nebulin. Neuromuscul Disord. 2021; 31(6):539-545. DOI: 10.1016/j.nmd.2021.03.006. View

McLaren W, Gil L, Hunt S, Riat H, Ritchie G, Thormann A . The Ensembl Variant Effect Predictor. Genome Biol. 2016; 17(1):122. PMC: 4893825. DOI: 10.1186/s13059-016-0974-4. View

Malfatti E, Romero N . Nemaline myopathies: State of the art. Rev Neurol (Paris). 2016; 172(10):614-619. DOI: 10.1016/j.neurol.2016.08.004. View

Wijnhoven T, de Onis M, Onyango A, Wang T, Bjoerneboe G, Bhandari N . Assessment of gross motor development in the WHO Multicentre Growth Reference Study. Food Nutr Bull. 2004; 25(1 Suppl):S37-45. DOI: 10.1177/15648265040251S105. View

Wallgren-Pettersson C, Sewry C, Nowak K, Laing N . Nemaline myopathies. Semin Pediatr Neurol. 2011; 18(4):230-8. DOI: 10.1016/j.spen.2011.10.004. View

Wang K, Li M, Hakonarson H . ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010; 38(16):e164. PMC: 2938201. DOI: 10.1093/nar/gkq603. View

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J . Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015; 17(5):405-24. PMC: 4544753. DOI: 10.1038/gim.2015.30. View

Colombo I, Scoto M, Manzur A, Robb S, Maggi L, Gowda V . Congenital myopathies: Natural history of a large pediatric cohort. Neurology. 2014; 84(1):28-35. PMC: 4336094. DOI: 10.1212/WNL.0000000000001110. View

van Kleef E, van Doorn J, Gaytant M, de Weerd W, Vosse B, Wallgren-Pettersson C . Respiratory muscle function in patients with nemaline myopathy. Neuromuscul Disord. 2022; 32(8):654-663. DOI: 10.1016/j.nmd.2022.06.009. View

10.

Sandaradura S, Bournazos A, Mallawaarachchi A, Cummings B, Waddell L, Jones K . Nemaline myopathy and distal arthrogryposis associated with an autosomal recessive TNNT3 splice variant. Hum Mutat. 2017; 39(3):383-388. PMC: 5805634. DOI: 10.1002/humu.23385. View

11.

Miyatake S, Mitsuhashi S, Hayashi Y, Purevjav E, Nishikawa A, Koshimizu E . Biallelic Mutations in MYPN, Encoding Myopalladin, Are Associated with Childhood-Onset, Slowly Progressive Nemaline Myopathy. Am J Hum Genet. 2016; 100(1):169-178. PMC: 5223057. DOI: 10.1016/j.ajhg.2016.11.017. View

12.

Lehtokari V, Kiiski K, Sandaradura S, Laporte J, Repo P, Frey J . Mutation update: the spectra of nebulin variants and associated myopathies. Hum Mutat. 2014; 35(12):1418-26. PMC: 4295925. DOI: 10.1002/humu.22693. View

13.

Lehtokari V, Pelin K, Sandbacka M, Ranta S, Donner K, Muntoni F . Identification of 45 novel mutations in the nebulin gene associated with autosomal recessive nemaline myopathy. Hum Mutat. 2006; 27(9):946-56. DOI: 10.1002/humu.20370. View

14.

Lehtokari V, Pelin K, Herczegfalvi A, Karcagi V, Pouget J, Franques J . Nemaline myopathy caused by mutations in the nebulin gene may present as a distal myopathy. Neuromuscul Disord. 2011; 21(8):556-62. DOI: 10.1016/j.nmd.2011.05.012. View

15.

Pelin K . Nebulin: Size matters for optimal muscle function. J Gen Physiol. 2021; 153(3). PMC: 7863720. DOI: 10.1085/jgp.202012848. View

16.

Sewry C, Laitila J, Wallgren-Pettersson C . Nemaline myopathies: a current view. J Muscle Res Cell Motil. 2019; 40(2):111-126. PMC: 6726674. DOI: 10.1007/s10974-019-09519-9. View

17.

Wada A, Kawakami M, Liu M, Otaka E, Nishimura A, Liu F . Development of a new scale for dysphagia in patients with progressive neuromuscular diseases: the Neuromuscular Disease Swallowing Status Scale (NdSSS). J Neurol. 2015; 262(10):2225-31. DOI: 10.1007/s00415-015-7836-y. View

18.

Wallgren-Pettersson C, Laing N . Report of the 70th ENMC International Workshop: nemaline myopathy, 11-13 June 1999, Naarden, The Netherlands. Neuromuscul Disord. 2000; 10(4-5):299-306. DOI: 10.1016/s0960-8966(99)00129-7. View

19.

Yuen M, Ottenheijm C . Nebulin: big protein with big responsibilities. J Muscle Res Cell Motil. 2020; 41(1):103-124. PMC: 7109182. DOI: 10.1007/s10974-019-09565-3. View

20.

Amburgey K, Acker M, Saeed S, Amin R, Beggs A, Bonnemann C . A Cross-Sectional Study of Nemaline Myopathy. Neurology. 2021; 96(10):e1425-e1436. PMC: 8055318. DOI: 10.1212/WNL.0000000000011458. View